Ovid Therapeutics Inc. Common Stock (OVID) is a publicly traded Healthcare sector company. As of November 5, 2026, OVID trades at $2.75 with a market cap of $468.71M and a P/E ratio of 0.00. OVID moved +0.36% today. Year to date, OVID is +65.24%; over the trailing twelve months it is +106.24%. Its 52-week range spans $0.24 to $3.11. Analyst consensus is strong buy with an average price target of $6.50. Rallies surfaces OVID's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
10 analysts cover OVID: 0 strong buy, 10 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $6.50.
| Metric | Value |
|---|---|
| Price | $2.75 |
| Market Cap | $468.71M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.11 |
| 52-Week Low | $0.24 |
| Volume | 2.97K |
| Avg Volume | 0 |
| Revenue (TTM) | $1.58M |
| Net Income | $-34.49M |
| Gross Margin | 0.00% |
10 analysts cover OVID: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.50.